Citations

Showing 10 of 108162 citations.

Paraneoplastic neurological syndrome: an evolving story
Jitprapaikulsan, Jiraporn , Thakolwiboon, Smathorn , Pittock, Sean J. , Dubey, Divyanshu , Paul, Pritikanta , Pittock, S J , Dubey, Divyanshu , Thakolwiboon, Smathorn , Mittal, Shivam Om

Mayo Clinic

Neuro-Oncology Practice | February 24, 2021 | Volume: 8 | Issue: 4 | Pages: 362-374

10.1093/nop/npab002 | PMID 34277016 Get It

AbstractParaneoplastic neurological syndrome (PNS) comprises a group of neurological disorders that result from a misguided immune response to the nervous system triggered by a distant tumor. These disorders frequently manifest before the diagnosis of the underlying neoplasm. Since the first reported case in 1888 by Oppenheim, the knowledge in this area has evolved rapidly. Several classic PNS have been described, such as limbic encephalitis, paraneoplastic cerebellar degeneration, encephalomyelitis, opsoclonus-myoclonus, sensory neuronopathy, Lambert-Eaton Myasthenic syndrome, and chronic gastrointestinal dysmotility. It is now recognized that PNS can have varied nonclassical manifestations that extend beyond the traditional syndromic descriptions. Multiple onconeural antibodies with high specificity for certain tumor types and neurological phenotypes have been discovered over the past 3 decades. Increasing use of immune checkpoint inhibitors (ICIs) has led to increased recognition of neurologic ICI-related adverse events. Some of these resemble PNS. In this article, we review the clinical, oncologic, and immunopathogenic associations of PNS.
1α,25-Dihydroxyvitamin D3 Encapsulated in Nanoparticles Prevents Venous Neointimal Hyperplasia and Stenosis in Porcine Arteriovenous Fistulas
Singh, Avishek , Cai, Chuanqi , Kilari, Sreenivasulu , Zhao, Chenglei , Simeon, Michael L. , Takahashi, Edwin A. , Kong, Hyunjoon , Macedo, Thanila A. , Misra, Sanjay , Singh, Avishek K, Takahashi, Edwin, Macedo, Thanila, Misra, Sanjay , Kong, Hyunjoon , Takahashi, Edwin A , Edelman, Elazer R. , Singh, Ravinder J. , Urban, Matthew W. , Kumar, Rajiv , Kilari, Sreenivasulu

Mayo Clinic

Journal of the American Society of Nephrology | February 24, 2021 | Volume: 32 | Issue: 4 | Pages: 866-885

10.1681/asn.2020060832 | PMID 33627344 Get It

Significance Statement Expression of immediate early response gene X-1 ( Iex-1 ), also known as Ier-3, is increased in venous neointimal hyperplasia (VNH) and stenosis in hemodialysis arteriovenous fistulas (AVF). In a porcine model, 1α,25(OH) 2 D 3 , an inhibitor of Ier3, reduced VNH/stenosis formation. The 1α,25(OH) 2 D 3 released in the perivascular AVF space from poly(lactic-co-glycolic acid) nanoparticles embedded in a Pluronic F127 hydrogel (1,25 NP) reduced Ier3 gene and protein expression, MCP-1, CD68, HIF-1α, and VEGF-A immunostaining. Concomitantly, blood flow, lumen area, pulse wave velocity, and Young’s modulus increased, and neointima area, peak systolic velocity, and wall shear stress decreased in 1,25 NP–treated vessels. RNA sequencing analysis identified 242 genes involved in inflammatory and apoptotic pathways that had decreased expression in 1,25 NP vessels. Background Few therapies prevent venous neointimal hyperplasia (VNH) and venous stenosis (VS) formation in arteriovenous fistulas (AVF). Expression of the immediate early response gene X-1 ( Iex-1 ), also known as Ier3, is associated with VNH and stenosis in murine AVFs. The study aimed to determine if local release of Ier3 long-acting inhibitor 1α,25(OH) 2 D 3 from poly(lactic-co-glycolic acid) (PLGA) nanoparticles embedded in a thermosensitive Pluronic F127 hydrogel (1,25 NP) could affect VNH/VS formation in a large animal model. Methods Immediately after AVF creation in a porcine model of renal failure, 1,25 NP or vehicle control was injected into the adventitia space of AVF outflow veins. Scanning electron microscopy and dynamic light scattering characterized drug and control nanoparticles. Animals were sacrificed 3 and 28 days later for gene expression, immunohistologic, magnetic resonance imaging and angiography, and ultrasound analyses. Whole transcriptome RNA sequencing with differential gene expression analysis was performed on outflow veins of AVF. Results Encapsulation of 1α,25(OH) 2 D 3 in PLGA nanoparticles formed nanoparticles of uniform size that were similar to nanoparticles without 1α,25(OH) 2 D 3 . The 1,25 NP–treated AVFs exhibited lower VNH/VS, Ier3 gene expression, and IER-3, MCP-1, CD68, HIF-1α, and VEGF-A immunostaining, fibrosis, and proliferation. Blood flow and lumen area increased significantly, whereas peak systolic velocity and wall shear stress decreased. Treatment increased Young’s modulus and correlated with histologic assessment of fibrosis and with no evidence of vascular calcification. RNA sequencing analysis showed changes in the expression of genes associated with inflammatory, TGFβ1, and apoptotic pathways. Conclusions Local release of 1,25 NP improves AVF flow and hemodynamics, and reduces stenosis in association with reduction in inflammation, apoptosis, and fibrosis in a porcine model of arteriovenous fistula.
De Quervain's Disease in Postpartum Women
Kouloumberis, Pelagia , Noland, Shelley S. , Kouloumberis, Pelagia E, Pflibsen, Lacey R.

Mayo Clinic

Journal of Women's Health | February 24, 2021 | Volume: 32 | Issue: 1 | Pages: 15-17

10.1089/jwh.2020.8966 | PMID 33625265 Get It

Regenerative Medicine Clinical Readiness
Yamada, Satsuki , Behfar, Atta , Terzic, André , Behfar, Atta , Terzic, Andre

Mayo Clinic

Regenerative Medicine | February 24, 2021 | Volume: 16 | Issue: 3 | Pages: 309-322

10.2217/rme-2020-0178 | PMID 33622049 Get It

Emerging Workforce Readiness in Regenerative Healthcare
Wyles, Saranya P. , Monie, Dileep D. , Paradise, Christopher R. , Meyer, Fredric B. , Hayden, Richard E. , Terzic, André , van Wijnen, Andre J , Terzic, Andre , Monie, Dileep D

Mayo Clinic

Regenerative Medicine | February 24, 2021 | Volume: 16 | Issue: 3 | Pages: 197-206

10.2217/rme-2020-0137 | PMID 33622054 Get It

Assessment of Image Quality for Selective Intracoronary Contrast-Injected CT Angiography in a Hybrid Angio-CT System: A Feasibility Study in Swine
Ha, Seongmin , Jung, Sunghee , Park, Hyung‐Bok , Shin, Sanghoon , Arsanjani, Reza , Hong, Youngtaek , Lee, Byoung Kwon , Jang, Yeonggul , Jeon, Byunghwan , Park, Se‐Il , Shim, Hackjoon , Chang, Hyuk‐Jae , Jung, Sung‐Hee , Jung, Sunghee , Arsanjani, Reza , Chang, Hyuk-Jae , Shim, Hackjoon , Park, Hyung Bok

Mayo Clinic

Yonsei Medical Journal | February 24, 2021 | Volume: 62 | Issue: 3 | Pages: 200

10.3349/ymj.2021.62.3.200 | PMID 33635009 Get It

Defining participatory health informatics – a scoping review
Gabarrón, Elia , Petersen, Carolyn , Denecke, Kerstin , Petersen, Carolyn , Denecke, Kerstin , Merolli, Mark

Mayo Clinic

Informatics for Health and Social Care | February 24, 2021 | Volume: 46 | Issue: 3 | Pages: 234-243

10.1080/17538157.2021.1883028 | PMID 33622168 Get It

Characterization of thunderclap headache in a reversible cerebral vasoconstriction syndrome case series
Amer, Mohammed , Amer, Mohammed A , Smith, Jonathan H. , Schwedt, Todd J.

Mayo Clinic

Headache: The Journal of Head and Face Pain | February 24, 2021 | Volume: 61 | Issue: 2 | Pages: 396-398

10.1111/head.14072 | PMID 33624834 Get It

Abstract Objectives To empirically address how thunderclap headache (TCH) is described in a relevant real‐world setting. Background TCH refers to a highly recognizable description of a severe headache that reaches maximum severity within 1 minute and endures for at least 5 minutes. The use of a numerical rating scale (NRS) to appraise TCH severity, as well as assessment of TCH progression in patients with pre‐existing headache at the time of TCH onset has not been previously evaluated. Methods This was a retrospective case series of adults with a diagnosis of reversible cerebral vasoconstriction syndrome (RCVS), identified through a search of the electronic health record. Individuals meeting International Classification of Headache Disorders, 3rd Edition criteria for acute headache attributed to RCVS were included. Attacks described using a verbal descriptor scale (VDS), NRS, or both were recorded to evaluate acute headache characteristics. Results In all, 56 individuals with available descriptions of 120 acute headaches were included in the study analysis. Patients were female (35, 62.5%) with a median age of 46 (range: 19–67). The majority of patients reported a RCVS trigger (39, 69.6%). Acute headaches were characterized using a VDS (52, 43.3%), NRS (51, 42.5%), or both (17, 14.1%). Acute headaches were always described as severe when a VDS was utilized, and with a median NRS of 10 (range: 4–10). Four patients (7%) did not have a single headache characterized as either severe or with a NRS 8 or greater. In the 10 cases for which there was a pre‐TCH baseline headache, it was either rated as mild or with a median NRS of 3 (range: 2–6). Conclusions TCH in RCVS can be recognized using either VDS or NRS, with a broader range of peak intensities than previously recognized. TCH remains recognizable despite pre‐existing baseline headache.
Effects of diminished positive mood and depressed mood upon verbal learning and memory among people with multiple sclerosis
Hoffmeister, Jordan , Basso, Michael R. , Whiteside, Douglas M. , Mulligan, Ryan , Arnett, Peter A. , Combs, Dennis R. , Whiteside, Douglas , Reynolds, Bradley

Mayo Clinic

Journal of Clinical and Experimental Neuropsychology | February 24, 2021 | Volume: 43 | Issue: 2 | Pages: 117-128

10.1080/13803395.2020.1853066 | PMID 33622171 Get It

Spinal Cord Injury from Fluoroscopically Guided Intercostal Blocks with Phenol
Laughlin, Ruple S.

Mayo Clinic

Pain Physician | February 23, 2021 | Volume: 2;17 | Issue: 2;3 | Pages: E219-E224

10.36076/ppj.2014/17/e219 Get It

Background: Image guided intercostal blocks are commonly performed and considered relatively safe. Chemical denervation is commonly used in clinical practice for treatment of chronic noncancer associated pain. Objective: To report a case of spinal cord injury resulting from fluoroscopically guided intercostal blocks with phenol. Study Design: Case report. Setting: Inpatient hospital service. Results/Case Report: A 53 year-old women was transferred from her local facility for acute onset of lower extremity paresis beginning shortly after right intercostal nerve injections of 2 mL of preservative-free phenol at the T7, 8, 9 levels. She had previous intercostal blocks for chronic rightsided mid thoracic/abdominal pain every 3 months for at least one year without sequelae. Within 20 minutes of the injection, she developed a sensation of right leg weakness and heaviness. Over several hours she developed worsening right leg weakness, and then left leg weakness, followed by urinary retention. Admission examination revealed severe right greater than left leg weakness, right lower extremity hyperesthesia to T10, absent lower extremity reflexes, and bilateral extensor plantar responses. Magnetic resonance imaging (MRI) of the entire spine demonstrated extensive T2/DWI hyperintensity in the central spinal cord from T1 to L1 with mild cord enlargement and enhancement at T7-9 (sites of injection). Extensive serum and cerebrospinal fluid (CSF) evaluation did not show any evidence of an infectious, inflammatory, or metabolic cause to her myelopathy. Repeat MRI of the entire spine demonstrated near complete resolution of the T2 signal abnormality. One month after presentation, despite radiographic improvement, the patient showed some clinical improvement, but remained walker dependent and with neurogenic bowel and bladder. Limitations: This report describes a single case report. Conclusion: This case offers several lessons for a pain specialist including 1) the potential for a neurologic catastrophe (spinal cord injury) from aqueous neurolytic intercostal blocks despite “safe” contrast spread; 2) potential mechanisms of neurogenic injury with intercostal blocks; 3) review of modifiable factors to decrease the risk of neurogenic injury; and 4) review of potential interventions (steroids, lumbar drain) to improve outcome in the setting of iatrogenic procedural related spinal cord injury. Key words: Phenol, myelopathy, paraparesis, chemical denervation, neurolysis, intercostal block, epidural spread, chronic pain, complication, transverse myelitis